deltatrials
Completed PHASE3 INTERVENTIONAL NCT00317447

The Efficacy of Oral Steroids in the Treatment of Acute Sciatica

Oral Steroids in the Treatment of Acute Sciatica A Randomized Controlled Study

Sponsor: Kaiser Permanente

Conditions Sciatica
Interventions Oral Prednisone
Updated 4 times since 2017 Last updated: Apr 20, 2006 Started: Feb 28, 2002 Completion: Apr 30, 2004
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00317447, this PHASE3 trial focuses on Sciatica and remains completed. Sponsored by Kaiser Permanente, it has been updated 4 times since 2002, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2017 — Jan 2021 [monthly]

    Completed PHASE3

    First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Kaiser Permanente
Data source: Kaiser Permanente

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations